fax: +33 1 42 16 10 49
Steatohepatitis/Metabolic Liver Disease
Article first published online: 14 DEC 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 55, Issue 2, pages 419–428, February 2012
How to Cite
Ratziu, V., Sheikh, M. Y., Sanyal, A. J., Lim, J. K., Conjeevaram, H., Chalasani, N., Abdelmalek, M., Bakken, A., Renou, C., Palmer, M., Levine, R. A., Bhandari, B. R., Cornpropst, M., Liang, W., King, B., Mondou, E., Rousseau, F. S., McHutchison, J. and Chojkier, M. (2012), A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology, 55: 419–428. doi: 10.1002/hep.24747
Potential conflict of interest: V.R. has received funding from Gilead Sciences, Astellas Pharma, and Roche and has served as a consultant for Astellas, Axcan, Genentech, Gilead, Roche, and Sanofi.
Supported by Gilead Sciences.
- Issue published online: 27 JAN 2012
- Article first published online: 14 DEC 2011
- Accepted manuscript online: 17 OCT 2011 10:31AM EST
- Manuscript Accepted: 14 SEP 2011
- Manuscript Received: 7 JUN 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.